Delivery Order SPE2DB20D2014-SPE2DB24FC95G

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $8.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 4,568,221,866 units of the pharmaceutical drug Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has a ceiling value of $1,470.84 and a period of performance through May 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,561,368,146 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a ceiling value of $1,075.96 and an ultimate completion date of June 29, 2023. This contract is not designated as a set-aside and was awarded as a firm-fixed-price contract. AmerisourceBergen holds a larger Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,562,162,932 units of pantoprazole sodium delayed-release 40 mg tablets in 90-count bottles. The $22,913.88 firm fixed-price delivery order has a completion date of September 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,292.92, is for the delivery of 4,568,174,061 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract is a firm-fixed-price delivery order, with a performance period extending through May 8, 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,678,906 units of Pantoprazole Sodium Delayed Release 40 mg Tablets. The contract has a total ceiling value of $1,442.63 and an ultimate completion date of April 24, 2023. The contract is a Firm Fixed Price (FFP) type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,565,644,526 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The $1,415.98 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of September 3, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,395.33, is for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets in quantities of 1,000. The contract is a firm fixed-price delivery order, with a period of performance through December 27, 2024. It is not designated as a set-aside contract. AmerisourceBergen...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,571.30, is for the delivery of 4,567,909,043 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. The award did not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,113.04 firm fixed-price delivery order is for the supply of 4,567,752,489 units of Pantoprazole Sodium Delayed-Release 40 mg tablets, with a period of performance through April 1, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,247.30, is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count containers. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC95G
    Delivery Order

This is a $8,769.52 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,697,881 units of pantoprazole sodium delayed-release 40 mg tablets. It has an ultimate completion date of September 6, 2024. This order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/5/24, 10:12 AM